Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital

13 May 2024 (11:17 - 12:25)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Maryem Assamti

Mohammed VI University Hospital Centre, Oujda (Morocco)

6 More presentations in this session

Presentation thumbnail

Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT

Doctor A. Silva (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction

Doctor V. Lopes (Coimbra, PT)

Abstract Slides Video

Presentation thumbnail

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Doctor A. Amanova (Aktobe, KZ)

Abstract Slides Video

Presentation thumbnail

Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Doctor V. De Simone (Legnago, IT)

Abstract Slides Video

Presentation thumbnail

Real world registry of use of SGLT2i in patients with HFrEF followed in a non-tertiary hospital.

Mr V. Martinez Mateo (Alcazar de San Juan, ES)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in interventional cardiology and pharmacology 2

The Event

Event poster

Heart Failure 2024

13 May 2024 11:17 CET

You may be interested in

Congress Presentation

Real-life management of heart failure: evaluation of medication optimisation in different phenotypes.

Congress Presentation

Drugs adherence after hospitalisation for heart failure: what have we learned from a French survey?

Congress Presentation

The HF paradox: effective therapies, limited impact - understanding the implementation and adherence gap

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources